Proposed transaction would provide Coeptis with two clinical stage assets leveraging NK cell therapies in relapsed or refractory acute myeloid leukemia (AML) and hospitalized respiratory infections, as well as preclinical programs for hematologic and solid tumors Clinical data from AML…

– International Journal of Molecular Sciences manuscript demonstrates robust pre-clinical data in two retinal disease models – Studies further demonstrate broad utility of melanocortin agonists in treating inflammatory conditions, especially in the eye CRANBURY, N.J., April 18, 2023…

ISELIN, N.J., April 18, 2023 /PRNewswire/ — Hexaware, a leading global provider of IT services and solutions, has been named a leader in the ISG Provider Lens™ Salesforce Ecosystem Partners US 2023 Quadrant Report for Implementation Services for Core Clouds Midmarket and Managed…

– Data to be presented at American Association for Cancer Research (AACR) Annual Meeting 2023 – MARLBOROUGH, Mass., April 18, 2023 /PRNewswire/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.